Literature DB >> 31275888

Serum miR-17 levels are downregulated in obese, African American women with elevated HbA1c.

Ariel Williams1,2, Dara Mc Dougal1, Willysha Jenkins1, Natasha Greene1, Clarlynda Williams-DeVane1,2, K Sean Kimbro1,2.   

Abstract

PURPOSE: Type 2 diabetes is heterogeneous disease characterized by several conditions including hyperglycemia. It is estimated that over 350 million people worldwide are suffering from type 2 diabetes and this number is expected to rise. According to the CDC, African Americans were observed to have a 40% higher incidence of diabetes compared to European Americans. Epigenetic modulating mechanisms such as microRNAs (miRNAs), have recently been established as a massive regulatory machine in metabolic syndrome, obesity and type 2 diabetes. In the present study, we aimed to investigate the serum levels of circulating miRNA 17 (miR-17) of obese, African American women with elevated HbA1c.
METHODS: We investigated miR-17 serum levels using qPCR. Then we used Pairwise Pearson Correlation Test to determine the relationship between clinical metabolic parameters and miR-17 serum levels.
RESULTS: The results indicated that participants with elevated HbA1c exhibited a down regulation of serum miR-17 levels compared to participants with normal HbA1c. MiR-17 was also correlated with serum calcium in participants with normal HbA1c.
CONCLUSIONS: The results suggest that serum miR-17 is involved in the regulation of glucose and calcium homeostasis, which may contribute to the development of type 2 diabetes.

Entities:  

Keywords:  African American; Calcium; Diabetes; HbA1C; Obesity; miR-17

Year:  2019        PMID: 31275888      PMCID: PMC6582114          DOI: 10.1007/s40200-019-00404-3

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  53 in total

1.  Circulating microRNAs in patients with coronary artery disease.

Authors:  Stephan Fichtlscherer; Salvatore De Rosa; Henrik Fox; Thomas Schwietz; Ariane Fischer; Christoph Liebetrau; Michael Weber; Christian W Hamm; Tino Röxe; Marga Müller-Ardogan; Angelika Bonauer; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2010-07-01       Impact factor: 17.367

2.  Impact of insulin resistance on enhanced monocyte adhesion to endothelial cells and atherosclerogenesis independent of LDL cholesterol level.

Authors:  Tomoya Mita; Hiromasa Goto; Kosuke Azuma; Wen Long Jin; Takashi Nomiyama; Yoshio Fujitani; Takahisa Hirose; Ryuzo Kawamori; Hirotaka Watada
Journal:  Biochem Biophys Res Commun       Date:  2010-04-09       Impact factor: 3.575

Review 3.  Inflammation and insulin resistance.

Authors:  Steven E Shoelson; Jongsoon Lee; Allison B Goldfine
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

Review 5.  Environmental and nutritional effects on the epigenetic regulation of genes.

Authors:  Robert Feil
Journal:  Mutat Res       Date:  2006-07-18       Impact factor: 2.433

6.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

Authors:  Dongsheng Cai; Minsheng Yuan; Daniel F Frantz; Peter A Melendez; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

Review 7.  Impact of diets and nutrients/drugs on early epigenetic programming.

Authors:  Claudine Junien
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

8.  Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987-1998.

Authors:  Mercedes R Carnethon; Latha P Palaniappan; Cecil M Burchfiel; Frederick L Brancati; Stephen P Fortmann
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

9.  Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity.

Authors:  Derrick J Gibbings; Constance Ciaudo; Mathieu Erhardt; Olivier Voinnet
Journal:  Nat Cell Biol       Date:  2009-08-16       Impact factor: 28.824

10.  MicroRNA expression in human omental and subcutaneous adipose tissue.

Authors:  Nora Klöting; Susan Berthold; Peter Kovacs; Michael R Schön; Mathias Fasshauer; Karen Ruschke; Michael Stumvoll; Matthias Blüher
Journal:  PLoS One       Date:  2009-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.